Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team.
During my research career, I became interested in different proteins involved in pathophysiological processes. Amongst them, the CD146 molecule, on which my team has worked for many years, is particularly exciting because it is both yin and yang, with involvement in many physiological processes such as angiogenesis or embryo implantation and, at the same time, a deleterious effect when expressed on tumour cells.
Understanding its mechanisms of action and proposing new diagnostic and therapeutic solutions is the ambitious project that we set with my team. To achieve this, we combine multiple and cross-cutting approaches from genes to proteins, from animal model cell tissue to humans, and from fundamental research to clinical application. This requires the use of advanced technology from transcriptomics proteomics, through imagery and the generation of antibodies. Marseille Immunopole is an extraordinary melting pot that allows us to work with many experts and combine these different approaches, with the common goal to bring new tests and new drugs for the benefit of patients.#recherche
Education is also one of the strategic components of the Marseille Immunopole project
AMU, AP-HM, VRCM
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
AMU, AP-HM, CIML, INNATE PHARMA
Immunotherapy is expanding to other cancers types: kidney cancer, bladder cancer, hepatocellular carcinoma, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma… but we are still only at the beginning of the story!
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.